DTRM-555 — clinical trials using this drug

Public-registry trials using DTRM-555 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas	Zhejiang DTRM Biopharma	Relapsed Chronic Lymphocytic Leukemia	PHASE2	8

Registry history

First registered study	September 2016 — NCT02900716 (Zhejiang DTRM Biopharma)
Registered studies matching this name	2 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Other Relapsed Chronic Lymphocytic Leukemia drugs

← Eichor home · All tracked trials · Relapsed Chronic Lymphocytic Leukemia studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →